drugset / Trial / NCT04592081

Dextenza Within Upper Lid Canaliculus Compared With Lower Lid Canaliculus Following Bilateral Cataract Extraction Surgery With PCIOL.

NCT04592081 ↗

Phase 4 Unknown 20 enrolled Kerry Assil, MD
RandomizedParallel-groupOpen-labelTreatment

Summary

Assessing DEXTENZA efficacy when placed within the upper eyelid canaliculus as opposed to the lower eyelid canaliculus.

Timeline

Start
2020-08-01
Primary completion
2021-02-01
Completion
2021-03-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 0.4 mg Other

Indications

No indication recorded.